热门资讯> 正文

Regenxbio因新董事股票购买而上涨

2026-08-28 21:57

Regenxbio (RGNX) is up ~3% in Friday morning trading after recently appointed director Gregory Austin Ciongoli bought more than 102,000 shares valued at more than $949,000.
An SEC filing shows that he bought 49,196 shares on Aug. 26 at an average price of $9.14 and 53,407 shares on Aug. 27 at an average price of $9.36.
Ciongoli, the founder and managing partner of Adiumentum Capital Management, joined the board on Aug. 25.

More on Regenxbio

Regenxbio: Sell-Off On Hunter Setback Presents A Risky Buy Opportunity
Regenxbio's Multi-Catalyst Setup Is Hard To Ignore (Rating Upgrade)
REGENXBIO Inc. (RGNX) Q2 2026 Earnings Call Transcript
REGENXBIO sinks as FDA puts RGX-121 gene therapy on clinical hold
Regenxbio outlines cash runway into Q4 2027 as RGX-202 targets module 1 BLA filing in Q3 2026

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。